| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.4 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.4 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |